Clinical trial
Aripiprazole Treatment for Methamphetamine Dependence Among High-risk…
NCT00497055 · San Francisco Department of Public Health, Other · Completed
Key facts
| NCT number | NCT00497055 |
|---|---|
| Title | Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals |
| Official title | Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals |
| Lead sponsor | San Francisco Department of Public Health, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Substance Abuse, HIV Infections |
| Intervention type | Drug |
| Interventions | Aripiprazole, Placebo |
| Enrollment | 90 |
| Start date | Mar 1, 2009 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Jul 6, 2007 |
| Last update posted | Mar 24, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: